Pharmaceuticals
Count Me a Covid-19 Skeptic, Including When It Comes to a Vaccine
The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.
Pfizer's Pullback Sweetens the Pill
The drugmaker is a buying opportunity right now.
7 Drug Stocks With the Right Medicine for Investors
These pharmaceutical favorites continue to make progress on a number of fronts including a Covid-19 vaccine.
I Wouldn't Buy Pfizer Shares on This Pop
I would wait until the next down day, and there will be one.
Alnylam Pharma Poised to Shoot Higher
The biopharmaceutical company shows bullish charts that signal a breakout to new all-time highs. The charts and indicators are bullish,
Regeneron Pharmaceuticals Has Made a Major Upside Breakout
Now that REGN has clearly broken out above the highs of 2015 there is no chart resistance.
Cutting Edge Biotech Cytokinetics Could Double in Price
Let's check the charts and indicators.
Low-Priced Amyris Could Surprise on the Upside
A look at the charts of this small-cap provider of bioscience services.
Covid-19 Complications, Grocery Store-y, More on Moderna: Market Recon
Plus, a closer look at Thursday's late-day rally and at actions impacting the nation's big banks.
I've Got the Perfect Prescription for Your Portfolio
Here's how to play CVS Health and avoid most negative investing side effects.